These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 33071243

  • 1. Features of Lead-Induced Tricuspid Regurgitation in Patients With Heart Failure Events After Cardiac Implantation of Electronic Devices　- A Three-Dimensional Echocardiographic Study.
    Nakajima H, Seo Y, Ishizu T, Iida N, Sato K, Yamamoto M, Machino-Ohtsuka T, Nogami A, Ohte N, Ieda M.
    Circ J; 2020 Nov 25; 84(12):2302-2311. PubMed ID: 33071243
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Outcomes in Patients With Heart Failure With Versus Without Lead-Induced Tricuspid Regurgitation After Cardiac Implantable Electronic Devices Implantations.
    Seo Y, Nakajima H, Ishizu T, Iida N, Sato K, Yamamoto M, Machino-Ohtsuka T, Nogami A, Ohte N, Ieda M.
    Am J Cardiol; 2020 Sep 01; 130():85-93. PubMed ID: 32622503
    [Abstract] [Full Text] [Related]

  • 3. 3D echocardiographic location of implantable device leads and mechanism of associated tricuspid regurgitation.
    Mediratta A, Addetia K, Yamat M, Moss JD, Nayak HM, Burke MC, Weinert L, Maffessanti F, Jeevanandam V, Mor-Avi V, Lang RM.
    JACC Cardiovasc Imaging; 2014 Apr 01; 7(4):337-47. PubMed ID: 24631508
    [Abstract] [Full Text] [Related]

  • 4. Cardiac implantable electronic device-induced tricuspid regurgitation: Implications and management.
    Murphy SP, Lew J, Yucel E, Singh J, Mela T.
    J Cardiovasc Electrophysiol; 2024 May 01; 35(5):1017-1025. PubMed ID: 38501386
    [Abstract] [Full Text] [Related]

  • 5. Lead-related tricuspid regurgitation and ventricle dysfunction: Current management and future perspectives.
    Chodór-Rozwadowska KE, Sawicka M, Morawski S, Lenarczyk R, Kalarus Z, Kukulski T.
    Adv Clin Exp Med; 2023 Sep 01; 32(9):1049-1061. PubMed ID: 36881368
    [Abstract] [Full Text] [Related]

  • 6. Echocardiographic assessment of tricuspid regurgitation and pericardial effusion after cardiac device implantation.
    Wiechecka K, Wiechecki B, Kapłon-Cieślicka A, Tymińska A, Budnik M, Hołowaty D, Jakubowski K, Michalak M, Świętoń E, Stolarz P, Steckiewicz R, Grabowski M, Scisło P, Kochanowski J, Filipiak KJ, Opolski G.
    Cardiol J; 2020 Sep 01; 27(6):797-806. PubMed ID: 31225634
    [Abstract] [Full Text] [Related]

  • 7. Long-Term Follow-Up of Mortality and Heart Failure Hospitalisation in Patients With Intracardiac Device-Related Tricuspid Regurgitation.
    Kanawati J, Ng ACC, Khan H, Yu C, Hyun K, Abed H, Kritharides L, Sy RW.
    Heart Lung Circ; 2021 May 01; 30(5):692-697. PubMed ID: 33132050
    [Abstract] [Full Text] [Related]

  • 8. Incidence, Risk Factors, and Prognosis of Tricuspid Regurgitation After Cardiac Implantable Electronic Device Implantation: A Systematic Review and Meta-analysis.
    Zhang XX, Wei M, Xiang R, Lu YM, Zhang L, Li YD, Zhang JH, Xing Q, Tu-Erhong ZK, Tang BP, Zhou XH.
    J Cardiothorac Vasc Anesth; 2022 Jun 01; 36(6):1741-1755. PubMed ID: 34389210
    [Abstract] [Full Text] [Related]

  • 9. Evolution and prognosis of tricuspid and mitral regurgitation following cardiac implantable electronic devices: a systematic review and meta-analysis.
    Yuyun MF, Joseph J, Erqou SA, Kinlay S, Echouffo-Tcheugui JB, Peralta AO, Hoffmeister PS, Boden WE, Yarmohammadi H, Martin DT, Singh JP.
    Europace; 2024 Jul 02; 26(7):. PubMed ID: 38812433
    [Abstract] [Full Text] [Related]

  • 10. Clinical utility of three-dimensional echocardiography in the evaluation of tricuspid regurgitation induced by implantable device leads.
    Cheng Y, Gao H, Tang L, Li J, Yao L.
    Echocardiography; 2016 Nov 02; 33(11):1689-1696. PubMed ID: 27539645
    [Abstract] [Full Text] [Related]

  • 11. Surgical treatment of tricuspid valve regurgitation in patients with cardiac implantable electronic devices: long-term results.
    Carino D, Sala A, Zancanaro E, Ruggeri S, Lapenna E, Del Forno B, Verzini A, Schiavi D, Castiglioni A, Alfieri O, Maisano F, De Bonis M.
    Eur J Cardiothorac Surg; 2022 Aug 03; 62(3):. PubMed ID: 35426906
    [Abstract] [Full Text] [Related]

  • 12. Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation.
    Addetia K, Harb SC, Hahn RT, Kapadia S, Lang RM.
    JACC Cardiovasc Imaging; 2019 Apr 03; 12(4):622-636. PubMed ID: 30947905
    [Abstract] [Full Text] [Related]

  • 13. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions.
    Arabi P, Özer N, Ateş AH, Yorgun H, Oto A, Aytemir K.
    Cardiol J; 2015 Apr 03; 22(6):637-44. PubMed ID: 26412607
    [Abstract] [Full Text] [Related]

  • 14. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.
    Höke U, Auger D, Thijssen J, Wolterbeek R, van der Velde ET, Holman ER, Schalij MJ, Bax JJ, Delgado V, Marsan NA.
    Heart; 2014 Jun 03; 100(12):960-8. PubMed ID: 24449717
    [Abstract] [Full Text] [Related]

  • 15. Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry.
    Taramasso M, Gavazzoni M, Pozzoli A, Alessandrini H, Latib A, Attinger-Toller A, Biasco L, Braun D, Brochet E, Connelly KA, de Bruijn S, Denti P, Deuschl F, Estevez-Louriero R, Fam N, Frerker C, Ho E, Juliard JM, Kaple R, Kodali S, Kreidel F, Kuck KH, Lauten A, Lurz J, Monivas V, Mehr M, Nazif T, Nickening G, Pedrazzini G, Praz F, Puri R, Rodés-Cabau J, Schäfer U, Schofer J, Sievert H, Tang GHL, Khattab AA, Thiele H, Unterhuber M, Vahanian A, Von Bardeleben RS, Webb JG, Weber M, Windecker S, Winkel M, Zuber M, Hausleiter J, Lurz P, Maisano F, Leon MB, Hahn RT.
    JACC Cardiovasc Interv; 2020 Mar 09; 13(5):554-564. PubMed ID: 31954676
    [Abstract] [Full Text] [Related]

  • 16. Impact of lead position on tricuspid regurgitation, ventricular function, and heart failure exacerbation and mortality after cardiac implantable electronic device implantation. Preliminary results from the PACE-RVTR Registry.
    Chodór-Rozwadowska K, Sawicka M, Morawski S, Kalarus Z, Kukulski T.
    Kardiol Pol; 2024 Mar 09; 82(1):53-62. PubMed ID: 38319145
    [Abstract] [Full Text] [Related]

  • 17. Tricuspid regurgitation associated with implantable electrical device insertion: A systematic review and meta-analysis.
    Tatum R, Maynes EJ, Wood CT, Deb AK, Austin MA, O'Malley TJ, Choi JH, Massey HT, Morris RJ, Pavri BB, Tchantchaleishvili V.
    Pacing Clin Electrophysiol; 2021 Aug 09; 44(8):1297-1302. PubMed ID: 34081789
    [Abstract] [Full Text] [Related]

  • 18. Echocardiography-guided Cardiac Implantable Electronic Device Implantation to Reduce Device Related Tricuspid Regurgitation: A Prospective Controlled Study.
    Marincheva G, Levi T, Perelshtein Brezinov O, Valdman A, Rahkovich M, Kogan Y, Laish-Farkash A.
    Isr Med Assoc J; 2022 Jan 09; 24(1):25-32. PubMed ID: 35077042
    [Abstract] [Full Text] [Related]

  • 19. Tricuspid valve disease and cardiac implantable electronic devices.
    Andreas M, Burri H, Praz F, Soliman O, Badano L, Barreiro M, Cavalcante JL, de Potter T, Doenst T, Friedrichs K, Hausleiter J, Karam N, Kodali S, Latib A, Marijon E, Mittal S, Nickenig G, Rinaldi A, Rudzinski PN, Russo M, Starck C, von Bardeleben RS, Wunderlich N, Zamorano JL, Hahn RT, Maisano F, Leclercq C.
    Eur Heart J; 2024 Feb 01; 45(5):346-365. PubMed ID: 38096587
    [Abstract] [Full Text] [Related]

  • 20. Tricuspid Regurgitation Following Implantation of Endocardial Leads: Incidence and Predictors.
    Lee RC, Friedman SE, Kono AT, Greenberg ML, Palac RT.
    Pacing Clin Electrophysiol; 2015 Nov 01; 38(11):1267-74. PubMed ID: 26234305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.